Hydroxylated cyclopenta[d]pyrimidines as AKT protein kinase inhibitors

The present invention provides compounds, including resolved enantiomers, resolved diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula I for use in oral dosage forms: Also provided are oral dosage forms comprising these compounds, methods of using the compou...

Full description

Saved in:
Bibliographic Details
Main Authors KALLAN, NICHOLAS, C, CHABOT, CHRISTINE, ZHANG, BIRONG, MITCHELL, IAN, S, DO, STEVEN, LIANG, JUN, XIAO, DENGMING, XU, RUI, SPENCER, KEITH, LEE, SCHLACHTER, STEPHEN, T, BENCSIK, JOSEF, R, BLAKE, JAMES, F, BANKA, ANNA, L, WALLACE, ELI, W, SAFINA, BRIAN
Format Patent
LanguageEnglish
French
German
Published 26.08.2015
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract The present invention provides compounds, including resolved enantiomers, resolved diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula I for use in oral dosage forms: Also provided are oral dosage forms comprising these compounds, methods of using the compounds and oral dosage forms of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer. Further provided are intermediate compounds from the synthesis of these compounds.
AbstractList The present invention provides compounds, including resolved enantiomers, resolved diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula I for use in oral dosage forms: Also provided are oral dosage forms comprising these compounds, methods of using the compounds and oral dosage forms of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer. Further provided are intermediate compounds from the synthesis of these compounds.
Author KALLAN, NICHOLAS, C
SAFINA, BRIAN
ZHANG, BIRONG
DO, STEVEN
WALLACE, ELI, W
MITCHELL, IAN, S
BENCSIK, JOSEF, R
BANKA, ANNA, L
SCHLACHTER, STEPHEN, T
LIANG, JUN
XIAO, DENGMING
CHABOT, CHRISTINE
XU, RUI
SPENCER, KEITH, LEE
BLAKE, JAMES, F
Author_xml – fullname: KALLAN, NICHOLAS, C
– fullname: CHABOT, CHRISTINE
– fullname: ZHANG, BIRONG
– fullname: MITCHELL, IAN, S
– fullname: DO, STEVEN
– fullname: LIANG, JUN
– fullname: XIAO, DENGMING
– fullname: XU, RUI
– fullname: SPENCER, KEITH, LEE
– fullname: SCHLACHTER, STEPHEN, T
– fullname: BENCSIK, JOSEF, R
– fullname: BLAKE, JAMES, F
– fullname: BANKA, ANNA, L
– fullname: WALLACE, ELI, W
– fullname: SAFINA, BRIAN
BookMark eNqNyjsOwjAMANAMMPC7gy-ABHTKCKhVJRaGbghVJnGFRbCjJAO5PQsHYHrLW5qZqNDCdH31ST81YCEPrrqgkaTgzd9jTfxmz0IZMMPxMkBMWogFXiyYCVie_OCiKa_NfMKQafNzZaBrh3O_pagj5YiOhMrYXg-NtXZnT_vmj_IFUPc1zg
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate Cyclopenta[d]pyrimidines hydroxylées en tant qu'inhibiteurs de la protéine AKT kinase
Hydroxylierte Cyclopenta[d]pyrimidine als AKT-Proteinkinase-Inhibitoren
ExternalDocumentID EP2399909B1
GroupedDBID EVB
ID FETCH-epo_espacenet_EP2399909B13
IEDL.DBID EVB
IngestDate Fri Jul 19 13:59:34 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP2399909B13
Notes Application Number: EP20110166123
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150826&DB=EPODOC&CC=EP&NR=2399909B1
ParticipantIDs epo_espacenet_EP2399909B1
PublicationCentury 2000
PublicationDate 20150826
PublicationDateYYYYMMDD 2015-08-26
PublicationDate_xml – month: 08
  year: 2015
  text: 20150826
  day: 26
PublicationDecade 2010
PublicationYear 2015
RelatedCompanies ARRAY BIOPHARMA, INC
GENENTECH, INC
RelatedCompanies_xml – name: ARRAY BIOPHARMA, INC
– name: GENENTECH, INC
Score 2.9965274
Snippet The present invention provides compounds, including resolved enantiomers, resolved diastereomers, solvates and pharmaceutically acceptable salts thereof,...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Hydroxylated cyclopenta[d]pyrimidines as AKT protein kinase inhibitors
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150826&DB=EPODOC&locale=&CC=EP&NR=2399909B1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LSwMxEB5KFfWmVbG-yEH2tri2-zwsQvdBEfpAqhREym420mBJF3dF-u-dCW31oreQkJAEJvPIzPcB3NiZxQk13Hzr-JlpB13H9Lntm9yzfM5FJhwdGhgM3f6T_TB1pg2Qm1oYjRP6pcERUaI4ynut3-vyJ4gV69zK6jaX2LW8TydhbKy9YwI377hG3AuT8SgeRUYUYcsYPoZUwhlYQQ8dpR20oj0ShuS5R0Up5W-Nkh7C7hgXU_URNIRqwX60IV5rwd5g_d-NzbXoVceQ9lcFpZwscFrB-IoviPiqzl6K13JF3FwFJbCzrGJotjENvyAVe5cK1RSTai5zScQ6J8DSZBL1TdzQbHv4WTLebr17Ck21VOIMmCscT3h-bqO1hR6SlRXE0xKIO9vxC7Sa2tD-c5nzf8Yu4IBukYKmHfcSmvXHp7hCrVvn1_q-vgGJQ4d8
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LSwMxEB6KivWmVbE-c5C9La7tPg9F6D5YtS-kSkGk7GYjBkta7Ir03zsT2upFbyEhIQlM5pGZ7wO4tDOLE2q4-drwM9MOmo7pc9s3uWf5nItMODo00O256aN9N3JGFZCrWhiNE_qlwRFRojjKe6nf69lPECvSuZXzq1xi1_QmGbYiY-kdE7h5wzWidise9KN-aIQhtozeQ4tKOAMraKOjtIkWtkfCED-1qShl9lujJLuwNcDFVLkHFaFqUA1XxGs12O4u_7uxuRS9-T4k6aKglJMJTisYX_AJEV-V2XPxMlsQN1dBCewsmzM025iGX5CKvUuFaopJ9SZzScQ6B8CSeBimJm5ovD78OB6st948hA01VeIImCscT3h-bqO1hR6SlRXE0xKIa9vxC7Sa6lD_c5njf8YuoJoOu51x57Z3fwI7dKMUQG24p7BRfnyKM9TAZX6u7-4bD1qKbw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Hydroxylated+cyclopenta%5Bd%5Dpyrimidines+as+AKT+protein+kinase+inhibitors&rft.inventor=KALLAN%2C+NICHOLAS%2C+C&rft.inventor=CHABOT%2C+CHRISTINE&rft.inventor=ZHANG%2C+BIRONG&rft.inventor=MITCHELL%2C+IAN%2C+S&rft.inventor=DO%2C+STEVEN&rft.inventor=LIANG%2C+JUN&rft.inventor=XIAO%2C+DENGMING&rft.inventor=XU%2C+RUI&rft.inventor=SPENCER%2C+KEITH%2C+LEE&rft.inventor=SCHLACHTER%2C+STEPHEN%2C+T&rft.inventor=BENCSIK%2C+JOSEF%2C+R&rft.inventor=BLAKE%2C+JAMES%2C+F&rft.inventor=BANKA%2C+ANNA%2C+L&rft.inventor=WALLACE%2C+ELI%2C+W&rft.inventor=SAFINA%2C+BRIAN&rft.date=2015-08-26&rft.externalDBID=B1&rft.externalDocID=EP2399909B1